SDS and trichloracetic acid were purchased from BDH Chemicals. The following were supplied by Sigma: DOC, bovine albumin (fraction V, crystallized, essentially globulin free), human albumin (crystallized, essentially globulin free), haemoglobin ( 2 x crystallized), human transferrin (substantially iron free), cytochrome c (horse heart, type HI), myoglobin (horse skeletal muscle, type I, salt free), ovalbumin (grade V, salt free), a-casein (bovine milk, low protease contamination), a-lactalbumin (bovine milk, type I), pepsin (EC 3.4.23.1, porcine stomach mucosa, 2 x crystallized), ribonuclease A (EC 3.1.27.5, bovine pancrease. type I-A, 5 x crystallized, essentially protease and salt free), lysozyme (EC 3.2.1.17, egg white, grade I, 3 x crystallized), achymotrypsinogen-A (bovine pancreas, type ll, 6 x crystallized, salt free) and a-chymotrypsin (EC 3.4.2 1.1, bovine pancreas, type 11, 3 x crystallized, salt free). All protein solutions (0.1 and 1.0 mg/ml) were freshly prepared gravimet rically.
Materials utid methods
SDS and trichloracetic acid were purchased from BDH Chemicals. The following were supplied by Sigma: DOC, bovine albumin (fraction V, crystallized, essentially globulin free), human albumin (crystallized, essentially globulin free), haemoglobin ( 2 x crystallized), human transferrin (substantially iron free), cytochrome c (horse heart, type HI), myoglobin (horse skeletal muscle, type I, salt free), ovalbumin (grade V, salt free), a-casein (bovine milk, low protease contamination), a-lactalbumin (bovine milk, type I), pepsin (EC 3.4.23.1, porcine stomach mucosa, 2 x crystallized), ribonuclease A (EC 3.1.27.5, bovine pancrease. type I-A, 5 x crystallized, essentially protease and salt free), lysozyme (EC 3.2.1.17, egg white, grade I, 3 x crystallized), achymotrypsinogen-A (bovine pancreas, type ll, 6 x crystallized, salt free) and a-chymotrypsin (EC 3.4.2 1.1, bovine pancreas, type 11, 3 x crystallized, salt free). All protein solutions (0.1 and 1.0 mg/ml) were freshly prepared gravimet rically.
Assuy method 1. Aqueous 5%) (w/v) SDS (30 pI) and aqueous 2% (w/v) DOC ( 5 0 p l ) were mixed with 50-250 pg o f protein in a sample volume of 250 pl. Water ( 3 ml) was added followed by 0.25 ml of 48% (w/v) trichloroacetic acid and the resulting turbidity monitored spectrophotometrically at 600 nm after 45 min.
Assay method 11. As above, but using a protein sample volume o f 3 ml without subsequent addition of 3 ml of water.
Kes1 I Its Fig. 1 indicates the turbidimetric response of bovine albumin, a-casein. a-chymotrypsin. cytochrome c and lysozyme t o trichloroacetic acid using assay method I with 30 p1 of 5% SDS and 5 0 pl of 2% DOC. The response to increasing protein amount was more linear and enhanced I-15-fold in comparison to the protein response to trichloroacetic acid in the absence of detergent (Fig. 1) . The response varied according to the protein. Thus, that of myoglobin resembled cytochrome c; human albumin and a-lactalbumin resembled bovine albumin; haemoglobin resembled lysozyme; transferrin resembled a-casein; and a-chymotrypsinogen, ovalbumin and y-globulins resembled a-chymotrypsin. Ribonuclease A gave an a-casein-type response in the presence of detergent, but a negligible response in its absence, while pepsin showed a negligible response with or without detergent.
Discussion
The turbidimetric response of increasing amounts of protein to added trichloroacetic acid was more linear and greatly enhanced in the presence of 0.03% DOC and 0.04% SDS. The addition of trichloroacetic acid to 0.03%) DOC (without protein or SDS) resulted in turbidity and rapid flocculation -this was eliminated by 0.01%, SDS (without protein), but unaffected by 50-250 pg of protein (without SDS). Since SDS alone or protein in 0.04% SDS (without DOC) failed to produce turbidity with trichloroacetic acid we suspect the assay generates turbidity from the interaction of DOC with TCA, that is, it indirectly monitors protein concentration via protein-SDS binding; the greater the protein amount the less residual SDS available to counteract the TCA-induced DOC turbidity/flocculation. DNA and RNA gave turbidity with TCA (A,,,,, = 0.2 with 250 pg), but characteristically failed to generate a protein-type enhancement with the detergents. Common biochemical reagents (5% (v/v) 2-mercaptoethanol, 0.2 M-glycine, 50 mM-EI)TA, 3 M-urea, 0.1 M-Tris/ HCI, pH 7 and 0.1 M-phosphate buffer pH 7) did not interfere with assay method I. A number of prostaglandins have the capacity to be 'cytoprotective', that is, thcy prevent cellular damagc to the mucosa of the stomach and gastrointcstinal tract which follows exposure to noxious agents such as mineral acids and non-steroidal anti-inflammatory compounds (Robert, 1979) . Cytoprotection is independent of the anti-secretory actions o f thcsc compounds. Protection with prostaglandins has also bcen demonstrated in other organs, including the liver. Pretreatment of animals with low doses of prostaglandin E2 or prostacyclin suppressed cellular damage caused by a range of hepatotoxins (Statchura et al., 1 Y8l; In previous studies we showed that preincubation of hamster hepatocytes with iloprost, a stable analogue of prostacyclin, significantly reduces the toxicity of paracetamol and its putative reactive metabolite N-acetyl-pbenzoquinoneimine (NABQI). Incubation with iloprost following exposure to paracetamol also prevented cytotoxicity (Nasseri-Sina et al., 1987) . In the present study, the effects of another prostaglandin, 16,16-dimethyI prostaglandin E 2 (dmPGE2) on the toxicity of paracetamol and NABQI were investigated. Exposure of hepatocytes to 2.0 mMparacetamol caused a time-dependent decrease in the viability, which was partially, but significantly, prevented by pretreatment of such cells with dmPGE, at concentrations between 10-M and lo-" M; the greatest protection being afforded by the highest concentration (Table 1A) . Similarly, preincubation of hepatocytes with concentrations of dmPGEz as low as l o -' , M prevented the loss of viability caused by 0.4 mM-NABQI (Table IB) . The prostaglandin also reduced the degree of plasma membrane blebbing (observed before cell death) that occurred following exposure of the cells to paracetamol or NABQI.
The effect of dmPGE, on the later stages of toxicity were investigated in a two-phase incubation model (Tee et al., 1986) . The initial metabolic phase of toxicity ( I ) was BIOCHEMICAL SOCIETY TRANSACTIONS 47.4 + h.9* 1.9 f 0.9** 43.2 f 9.8 7.9 f 2.5** I 1.4 f 2.5** separated, by washout of paracetamol, from the later stages (phase 11) of ensuing cell death. During phase I, hepatocytes were incubated with paracetamol for 45-60 min at the end of which time there was no loss of viability. After 3 h of phase I1 incubation, the viability of the hepatocytes was reduced to 45.2f3.5% of that of control cells (Table 1C) . When the cells were treated with 1.25 mM-N-acetylcysteine during phase 11, their viability after 3 h was maintained at 79.5 f 5.2% and membrane blebbing was prevented. Treatment of cells during phase I1 with 10-" M-dmPGE2 also significantly reduced loss of viability and decreased the degree of plasma membrane blebbing.
Evidence that dmPGE, did not protect the hepatocytes by inhibiting paracetamol metabolic activation of NABQI was obtained with hepatic microsomes: the formation of 3-Sglutathionyl paracetamol (Seddon er al., 1986) was not inhibited by dmPGE2, except at l o -" M, where inhibition was by only 16%, not sufficient to explain the degree of cytoprotection that was observed.
One of the early biochemical events occurring during paracetamol toxicity is depletion of cellular glutathione stores. Exposure of hepatocytes to 2.0 mM-paracetamol for
Introduction
Cytochrome P-450, a multi-isoenzyme family of haemoproteins, plays an important role in the elimination of a wide range of xenobiotics. Although extrahepatic tissues usually contribute little towards this process, they often generate reactive metabolites and thus are targets for cytotoxicity. This phenomenon is dictated largely by the tissue-specific expression and inducibility of the isoenzymes of cytochrome 1'-450. For example, in rabbit lung the constitutive phenobarbitone (PB)-inducible isoenzyme, form 2 , is almost exclusively responsible for the bioactivation of 4-ipomeanol and several other toxic chemicals (Domin et al., 1986) . This may also occur in the rat (Baron et al., 1987). antibody; IGSS, immunogold-silver staining.
Abbreviations used: PB, phenobarbitone; MAb, monoclonal Rat hepatic cytochromes 1'-450 b and e (1'-450 b/e) are co-induced by PB and other compounds. Extrahepatic induction, however, appears to vary with the species, e.g. in the rat, renal cytochrome P-450 does not respond to PB whereas in the rabbit it does (Rush et al., 1983) . This paper describes the localization of the major PB-inducible form( s) (b/e) in rat tissues, as determined by immunohistochemistry.
Results and discussion
Monoclonal antibodies (MAbs), 1 /4 and 1 0/ 1, specific to the major PB-inducible form of cytochrome 1'-450 b/e in the rat were prepared as described previously (Sesardic et al., 1986) .
Immunocytochemical localization of cytochrome P-450 was accomplished using the indirect immunoperoxidase two stage technique (van Noorden, 1986) or immunogold-silver staining (Springall et al., 1984) . Controls included replacement of the primary antiserum with diluent alone, with serum or with inappropriate antibody. Inducibility of cytochrome P-450 in tissues was assessed qualitatively from differential changes in staining intensities of sections exposed to varying MAb dilutions.
